NASDAQ
CytoMed Therapeutics Limited (GDTC) has a interest coverage ratio of -219.72x as of Tuesday, July 14, 2026. This represents a 317.37% decrease compared to its 12-month average of -52.64x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.